Alliance Global Partners raised the firm’s price target on IperionX (IPX) to $32 from $24.50 and keeps a Buy rating on the shares. The company announced 2024 results and provided a corporate update with respect to its titanium manufacturing facility in Virginia, the analyst tells investors in a research note. The firm believes the stage is set for production to ramp and views 2025 as “catalyst-rich” for IperionX. It expects the titanium production ramp to serve as an inflection point for the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IPX: